Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.
about
A national clinical decision support infrastructure to enable the widespread and consistent practice of genomic and personalized medicineDeveloping multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometryAge-related differences in plasma proteins: how plasma proteins change from neonates to adultsEmerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension.Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and bloodPrognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injuryPlasma levels of apolipoprotein A1 in malaria-exposed primigravidae are associated with severe anemiaSex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis studyCardiovascular proteomics: implications for clinical applicationsCirculating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling.African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertensionSerum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarraysBeyond mortality: future clinical research in acute lung injury.Proteomics and mass spectrometry: what have we learned about the heart?Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomesRedox proteomics identification of oxidatively modified myocardial proteins in human heart failure: implications for protein function.Novel effects of hormonal contraceptive use on the plasma proteome.Biomarkers in acute lung injury--marking forward progress.Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers.Plasma Shh levels reduced in pancreatic cancer patientsBiomarkers of HIV-1 associated dementia: proteomic investigation of sera.Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites.Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function.Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertensionAssociation of serum myeloperoxidase with the ankle-brachial index and peripheral arterial disease.Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation.The genetics of congestive heart failure.Industrialized MS-based proteomics in the search for circulating biomarkers.A roadmap for successful applications of clinical proteomics.Protein biomarker quantification by mass spectrometry.Advantages of multiplex proteomics in clinical immunology: the case of rheumatoid arthritis: novel IgXPLEX™: planar microarray diagnosis.Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis.Beyond fishing: the role of discovery proteomics in mechanistic lung research.Application of clinical proteomics in acute respiratory distress syndrome.Biomarkers of ARDS: what's new?Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays.Application of Large Scale Aptamer-Based Proteomic Profiling to "Planned" Myocardial Infarctions.Hydrogel nanoparticle harvesting of plasma or urine for detecting low abundance proteins.Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers.
P2860
Q27497190-E47D7E28-EF23-457B-BE76-1467E145E331Q28395328-A9D5D34F-05E4-47C2-918A-7824310B92FDQ28477212-782F89F1-C8A3-4ED1-B52A-F9DA1B0146C8Q30234679-70AB432F-A134-44EC-A942-10F1972B5720Q30477731-411E7215-39DB-40D7-AF98-CBAB2C98B781Q31045532-F8BC5E88-5690-4307-BDA9-F5FE9CC43EE9Q33512670-2ECA9FE4-EDD8-419D-B8F7-62D45BB502EBQ33526296-5310745E-8286-4A6D-B6F9-B216526F95F9Q33530066-7A028421-3E55-45A9-B50E-D94923F5183EQ33579184-C3548689-3F33-4200-9AC9-2539D9E4FB97Q33694691-F3DE3B4D-4FA5-4596-BA11-33A89DBBF66FQ33804131-C72D4434-2696-461D-81F1-666B6F0F6AEDQ33829507-058BE43E-F18E-4F55-B9AE-CB49D19FB82EQ33868624-B86D661E-33A3-4A2A-B236-4A513FC1B944Q33940880-7E9EF829-F35A-4080-A46B-F8FAE9E0B141Q34075434-2DF8F8CA-9F54-4412-8C60-420B7A9EACECQ34273494-ABF8013C-191B-412F-A30C-BDD66C9FFE38Q34416417-3ED903FF-FD51-4588-B9B5-2EBBF1F07862Q35100674-69317C60-3D6E-4ECE-98D8-398858F8A226Q35571271-37A49E7F-3BC4-432A-9DCF-792581309C9EQ36113636-CDB3A29D-5DE1-4B36-BB7F-89BC6AB68E45Q37152990-D643E095-9B6A-459D-AD81-BD848C65C218Q37172222-591EABE5-150E-4EFF-9952-B44C74AED81EQ37211307-06490E4B-74F8-4DD8-A569-032B070A5F12Q37364330-C9E0F625-6CCB-4DFD-AFCC-82E932A02EC1Q37364334-062D356C-32B0-4399-8B91-DFDC8CEDA15FQ37377689-29ABCC7E-8A4A-4AEF-8692-EE1981FB3223Q37720223-B0665D5A-AD72-4CFC-B5EB-C942350E76B2Q37810154-2ACBFBB2-A620-41BE-87D6-013A751C6DB3Q37869461-259E94E3-3DCA-48FC-A4AF-6219034E0480Q39913983-1A5A8A95-2C45-4EF7-8833-6B2C6BD8DDE2Q39920872-E7AFCD1F-436B-41B2-977A-B8327A2E11E5Q41773090-9662E194-9441-42C6-BBA5-2CB1C6A2F5B7Q42574642-93355737-BD1B-4265-9444-760C98D8BA55Q42754821-063AA0EB-EE3A-498A-88DD-A86FA728D9E9Q46126147-11B640FA-6635-4C30-A182-14A20AA3FDCAQ46504958-056234CD-9416-4ECF-92A9-56C4DFF48AFAQ47313704-45075AE6-AD99-4275-8D2F-9E7AD7AEEC48Q49370842-4AF50520-520E-434A-9605-BD9F9BACC9B1Q52354794-7CE8875D-7E6F-4D4F-AD3F-6C20AA3CE867
P2860
Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Challenges in translating plas ...... Clinical Proteomics Programs.
@ast
Challenges in translating plas ...... Clinical Proteomics Programs.
@en
type
label
Challenges in translating plas ...... Clinical Proteomics Programs.
@ast
Challenges in translating plas ...... Clinical Proteomics Programs.
@en
prefLabel
Challenges in translating plas ...... Clinical Proteomics Programs.
@ast
Challenges in translating plas ...... Clinical Proteomics Programs.
@en
P2093
P2860
P50
P1476
Challenges in translating plas ...... I Clinical Proteomics Programs
@en
P2093
Eric W Klee
Frank Accurso
George G Klee
Gordon R Bernard
Iftikhar Kullo
Marc Sabatine
Pothur Srinivas
Richard M Caprioli
Robert E Gerszten
Theresa A Laguna
P2860
P304
P356
10.1152/AJPLUNG.00044.2008
P577
2008-05-02T00:00:00Z